Vanguard Russell 2000 Growth ETF (VTWG) Is At $137.44 Formed Wedge; Invuity (IVTY) Sellers Decreased By 4.21% Their Shorts

Vanguard Russell 2000 Growth ETF (VTWG) formed wedge up with $142.94 target or 4.00% above today’s $137.44 share price. Vanguard Russell 2000 Growth ETF (VTWG) has $611.41 million valuation. The ETF increased 0.44% or $0.6 during the last trading session, reaching $137.44. About 8,324 shares traded or 1.81% up from the average. Vanguard Russell 2000 Growth ETF (NASDAQ:VTWG) has risen 25.96% since January 3, 2017 and is uptrending. It has outperformed by 9.26% the S&P500.

Invuity Incorporated (NASDAQ:IVTY) had a decrease of 4.21% in short interest. IVTY’s SI was 1.10M shares in January as released by FINRA. Its down 4.21% from 1.15 million shares previously. With 49,500 avg volume, 22 days are for Invuity Incorporated (NASDAQ:IVTY)’s short sellers to cover IVTY’s short positions. The SI to Invuity Incorporated’s float is 9.72%. The stock increased 0.82% or $0.05 during the last trading session, reaching $6.15. About 14,587 shares traded. Invuity, Inc. (NASDAQ:IVTY) has risen 50.92% since January 3, 2017 and is uptrending. It has outperformed by 34.22% the S&P500.

Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company has market cap of $105.41 million. The firm integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It currently has negative earnings. It offers various illuminated surgical devices, including Eikon LT Illuminated and Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; and Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries.

Among 4 analysts covering Invuity Inc (NASDAQ:IVTY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invuity Inc had 7 analyst reports since August 29, 2016 according to SRatingsIntel. Northland Capital maintained Invuity, Inc. (NASDAQ:IVTY) rating on Tuesday, June 13. Northland Capital has “Buy” rating and $1300 target. The stock has “Buy” rating by Piper Jaffray on Tuesday, July 25. Craig Hallum initiated Invuity, Inc. (NASDAQ:IVTY) on Monday, August 29 with “Buy” rating. The firm has “Buy” rating by Northland Capital given on Wednesday, July 26. As per Monday, September 19, the company rating was initiated by Lake Street.